» Authors » Vilmundur Gudnason

Vilmundur Gudnason

Explore the profile of Vilmundur Gudnason including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 703
Citations 67131
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bjarnadottir S, Aspelund T, Gudmundsson E, Gudnason V, Andersen K
BMJ Open . 2025 Mar; 15(3):e087815. PMID: 40081976
Objectives: Temporal trends in the incidence of ST-elevation myocardial infarction (STEMI) have been declining in many countries, while the incidence of non-ST elevation myocardial infarction (NSTEMI) has reached a plateau...
2.
Twait E, Gudnason V, Launer L, Gerritsen L, Geerlings M
Neurodegener Dis . 2025 Mar; :1-15. PMID: 40081341
Introduction: Advancing age is associated with global brain atrophy. Cross-sectional studies have found sex differences in neuroanatomy; however, longitudinal studies assessing sex differences in neurodegeneration are currently scarce. The effects...
3.
Roselli C, Surakka I, S Olesen M, Sveinbjornsson G, Marston N, Choi S, et al.
Nat Genet . 2025 Mar; 57(3):539-547. PMID: 40050429
Atrial fibrillation (AF) is the most common heart rhythm abnormality and is a leading cause of heart failure and stroke. This large-scale meta-analysis of genome-wide association studies increased the power...
4.
Lee S, Miller C, Bentley A, Brown M, Nagarajan P, Noordam R, et al.
Res Sq . 2025 Mar; PMID: 40034430
Background Gene-environment interactions may enhance our understanding of hypertension. Our previous study highlighted the importance of considering psychosocial factors in gene discovery for blood pressure (BP) but was limited in...
5.
Bortnick A, Austin T, Hamerton E, Gudmundsdottir V, Emilsson V, Jennings L, et al.
J Am Heart Assoc . 2025 Feb; 14(5):e036336. PMID: 40008515
Background: Calcific aortic valve disease (CAVD), and ensuing severe aortic stenosis (AS), is the foremost valvular disorder of aging, yet preventive therapies are lacking. A better understanding of the molecular...
6.
Arnold M, Buyukozkan M, Doraiswamy P, Nho K, Wu T, Gudnason V, et al.
Nat Commun . 2025 Feb; 16(1):1910. PMID: 39994231
Impaired glucose uptake in the brain is an early presymptomatic manifestation of Alzheimer's disease (AD), with symptom-free periods of varying duration that likely reflect individual differences in metabolic resilience. We...
7.
Bankier S, Gudmundsdottir V, Jonmundsson T, Bjarnadottir H, Loureiro J, Wang L, et al.
medRxiv . 2025 Feb; PMID: 39974043
Variations in blood protein levels have been associated with a broad spectrum of complex diseases, including atherosclerotic cardiovascular disease (ACVD). These associations highlight the intricate interplay between local (e.g., cardiovascular)...
8.
Kanis J, Johansson H, McCloskey E, Liu E, Schini M, Vandenput L, et al.
Osteoporos Int . 2025 Feb; PMID: 39955689
Introduction: RA is a well-documented risk factor for subsequent fracture that is incorporated into the FRAX algorithm. The aim of this study was to evaluate, in an international meta-analysis, the...
9.
Hu Y, Meirelles O, Shiroma E, Satizabal C, Seshadri S, Tracy R, et al.
Alzheimers Dement . 2024 Dec; 20(12):8556-8565. PMID: 39718159
Introduction: Peripheral risk factors (PRFs) may correlate with dementia plasma biomarkers, potentially reflecting peripheral rather than brain health. This study explores the associations between PRFs and plasma biomarkers glial fibrillary...
10.
Fino N, Inker L, Greene T, Adingwupu O, Coresh J, Seegmiller J, et al.
PLoS One . 2024 Dec; 19(12):e0313154. PMID: 39621675
Assessing glomerular filtration rate (GFR) is critical for diagnosis, staging, and management of kidney disease. However, accuracy of estimated GFR (eGFR) is limited by large errors (>30% error present in...